Scholarlink

<p>Epigallocatechin-3-gallate (EGCG), the primary catechin in green tea, has emerged as a paradigmatic multi-target molecule capable of modulating convergent molecular processes underlying neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Through its dual action as a molecular chaperone and signalling rebalancer, EGCG redefines the concept of natural compounds as network regulators rather than isolated antioxidants. This review integrates mechanistic, biochemical, and translational insights to elucidate how EGCG influences protein aggregation, neuroinflammation, redox signalling, and synaptic resilience, and proposes future molecular engineering strategies to enhance its therapeutic potential.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Epigallocatechin-3-gallate (EGCG) as a molecular chaperone and network rebalancer in neurodegenerative diseases

  • 期刊论文

  • 发表日期：

    2026年6月15日

查看全文
  • Husni Farah,
  • Media Hamed Ahmed,
  • Shaker Al-Hasnaawei,
  • H. Malathi,
  • Swati Mishra,
  • Anima Nanda,
  • Vimal Arora,
  • Ashish Singh Chauhan

摘要

Epigallocatechin-3-gallate (EGCG), the primary catechin in green tea, has emerged as a paradigmatic multi-target molecule capable of modulating convergent molecular processes underlying neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Through its dual action as a molecular chaperone and signalling rebalancer, EGCG redefines the concept of natural compounds as network regulators rather than isolated antioxidants. This review integrates mechanistic, biochemical, and translational insights to elucidate how EGCG influences protein aggregation, neuroinflammation, redox signalling, and synaptic resilience, and proposes future molecular engineering strategies to enhance its therapeutic potential.

Graphical abstract